Although the vaccine yet to go through human trials, it could be an alternative to the mRNA vaccines widely used for COVID-19.Swapna MukherjeeDepartment of MicrobiologyScience & culture
“health insurance providers recognize the importance of these vaccines and continue to encourage everyone to get a covid-19 vaccine. “ahip members are covering the new covid-19 shots with no cost-sharing when obtained through a network provider,” the statement said. “we...
We find striking consistency across studies. In all samples except Rwanda, including those from Russia and the United States, respondents identify the health system as the most trustworthy source to help them decide whether to take the COVID-19 vaccine. The average across LMIC samples is 48.1% ...
China classifies all counties as low-risk for the novel coronavirus disease (COVID-19) from Thursday, Mi Feng, spokesperson for the National Health Commission (NHC), said at a media briefing. The move came as no domestic cases have been reported in the Chinese mainla...
(Xinhua) -- Inadequate investment and funding for tuberculosis control in Africa is jeopardizing the efforts to meet the global target of ending the disease by 2030, as the COVID-19 pandemic threatens to roll back progress made so far on the continent, said the World Health Organization (WHO...
The situation in rural China has attracted much attention during the recent wave of COVID-19 infection. CGTN reporter Guo Tianqi visited a village in southwest China's Sichuan Province to see what's going on there.
Trial lead, Professor Kim Mulholland from the MCRI, said the testing would be crucial as the world begins to deal with waning immunity at the current stage of the pandemic. "All countries are struggling with the issue of how best to maintain COVID-19 immunity in their populations," said Mu...
However, Prof Lang said it was possible the virus was spreading “differently” in Africa, including with more asymptomatic cases. It was possible, too, that people with underlying conditions such as tuberculosis might respond differently to Covid-19, conceivably making patients more resistant, becau...
"Inhaled heparin is a promising new possibility to provide a low-cost, safe and effective treatment for COVID-19 that is available and affordable to low and middle-income countries around the globe." More information:Frank M. P. Haren et al, Inhaled nebulised unfractionated heparin for the tr...
byOsaka University Credit: Osaka University When dealing with coronavirus disease, it is essential for healthcare personnel to wear appropriate personal protective equipment. However, the unexpectedly rapid spread of the disease has led to a shortage of important components of personal protective equipment...